M. Spalato-Ceruso

Gene expression profiling improves prognostication by nomogram in patients with soft‐tissue sarcomas

C. Lucchesi, Y. Laizet, M. Toulmonde, 2022, Cancer communications.

Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft‐tissue sarcomas

Y. Laizet, M. Toulmonde, A. Italiano, 2023, Cancer communications.

Genome-wide CRISPR/Cas9 library screening identified ATM signaling network genes as critical drivers for resistance to ATR inhibition in soft-tissue sarcomas: synthetic lethality and therapeutic implications

A. Italiano, A. Laroche-Clary, V. Vélasco, 2023, Experimental Hematology & Oncology.

Implementing a Machine Learning Strategy to Predict Pathologic Response in Patients With Soft Tissue Sarcomas Treated With Neoadjuvant Chemotherapy.

M. Toulmonde, A. Italiano, A. Crombé, 2021, JCO clinical cancer informatics.

Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket study

X. Buy, M. Toulmonde, A. Italiano, 2022, Journal of Hematology & Oncology.

New strategies in soft tissue sarcoma treatment

M. Spalato-Ceruso, Nathan El Ghazzi, Antoine Italiano, 2024, Journal of hematology & oncology.